AYTU
Price
$2.27
Change
-$0.02 (-0.87%)
Updated
Sep 1, 02:12 PM (EDT)
Capitalization
24.36M
28 days until earnings call
Intraday BUY SELL Signals
ZYBT
Price
$1.65
Change
-$0.08 (-4.62%)
Updated
Sep 1 closing price
Capitalization
77.96M
Intraday BUY SELL Signals
Interact to see
Advertisement

AYTU vs ZYBT

AYTU vs ZYBT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AYTU vs. ZYBT commentary
Sep 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a Buy and ZYBT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2026
Stock price -- (AYTU: $2.29 vs. ZYBT: $1.73)
Brand notoriety: AYTU and ZYBT are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYTU: 54% vs. ZYBT: 1%
Market capitalization -- AYTU: $24.36M vs. ZYBT: $77.96M
AYTU [@Pharmaceuticals: Generic] is valued at $24.36M. ZYBT’s [@Pharmaceuticals: Generic] market capitalization is $77.96M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYTU’s FA Score shows that 1 FA rating(s) are green whileZYBT’s FA Score has 0 green FA rating(s).

  • AYTU’s FA Score: 1 green, 4 red.
  • ZYBT’s FA Score: 0 green, 5 red.
According to our system of comparison, ZYBT is a better buy in the long-term than AYTU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYTU’s TA Score shows that 5 TA indicator(s) are bullish while ZYBT’s TA Score has 6 bullish TA indicator(s).

  • AYTU’s TA Score: 5 bullish, 5 bearish.
  • ZYBT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ZYBT is a better buy in the short-term than AYTU.

Price Growth

AYTU (@Pharmaceuticals: Generic) experienced а -0.87% price change this week, while ZYBT (@Pharmaceuticals: Generic) price change was -11.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.06%. For the same industry, the average monthly price growth was +4.86%, and the average quarterly price growth was +36.19%.

Reported Earning Dates

AYTU is expected to report earnings on Sep 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.06% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZYBT($78M) has a higher market cap than AYTU($24.4M). ZYBT YTD gains are higher at: 50.435 vs. AYTU (-11.923).
AYTUZYBTAYTU / ZYBT
Capitalization24.4M78M31%
EBITDA-27.16MN/A-
Gain YTD-11.92350.435-24%
P/E RatioN/AN/A-
Revenue56.6MN/A-
Total Cash26.7MN/A-
Total Debt21.8MN/A-
FUNDAMENTALS RATINGS
AYTU: Fundamental Ratings
AYTU
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
60
SEASONALITY SCORE
1..100
6

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AYTUZYBT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
AYTU
Daily Signal:
Gain/Loss:
ZYBT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGIAX42.03N/A
N/A
Putnam Focused Equity A
MITGX33.74N/A
N/A
MFS Massachusetts Investors Tr R1
PGFIX88.95N/A
N/A
Virtus Silvant Focused Growth Inst
VNGAX11.19N/A
N/A
Vontobel Global Equity A
BLYAX40.71-0.10
-0.25%
American Beacon Man Lg Cp Growth A